Course Details
Course Title CRISPR-Based Gene Therapy for the Induction of Fetal Hemoglobin in Sickle Cell Disease
Presented Date 02/27/2025
Expiration Date 02/27/2028

Presenter(s) Haydar Frangoul, M.D., MS
This Presenter does not have any relevant Financial Relationships to disclose.

This activity was not supported by an education grant or any in-kind support.

The Medical University of South Carolina designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Description This is an online grand round from the Department of Medicine
Haydar Frangoul, M.D., MS Director of Pediatric Hematology/Oncology and Stem Cell Transplant, Sarah Cannon Research Institute at TriStar Centennial Children’s Hospital
Objectives Recognize the role of persistence of fetal hemoglobin in sickle cell disease; How does CRISPR gene editing work to modify hematopoietic stem cells; identify results of gene editing to induce fetal hemoglobin in individuals with sickle cell disease
Step 1
Watch the course video.
Step 2
1. The below link will take you to the CME Tracker Publisher Portal. Please make sure that the settings on your computer, tablet or phone allows for "pop-ups"
2. Sign in (or create an account) to generate certificate
3. The activity code will self-populate, click “Submit”
4. A pop-up box will appear that says “This activity has a required test” click “ok”
5. Complete the quiz. You will need to score 100%. You can retake the quiz as many times as necessary.
6. After completing the quiz, click “Continue” and “ok” when the score of 100% appears
7. Complete the evaluation and then “Submit”
8. Print or save your credit letter

CME Tracker - Claim Credit

Help

If you experience technical or accessibility issues, have questions about CME webcasting, or need assistance with webcast CME credit, please email us.